Characterization of highly antimicrobial-resistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009-2010

Journal of Medical Microbiology

Volumn 61, Issue 1, 2012, Pages 42-48

  Zhang, Bo ^a   Gertz, Robert E ^b   Liu, Zhiyong ^a   Li, Zhongya ^b   Fu, Weiling ^a   Beall, Bernard ^b  

^a SOUTHWEST HOSPITAL   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; RIFAMPICIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHINESE; HOSPITAL; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 83755172959     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.035675-0     Document Type: Article

References (17)

1. Beall, B., McEllistrem, M. C., Gertz, R. E., Jr, Wedel, S., Boxrud, D. J., Gonzalez, A. L., Medina, M. J., Pai, R., Thompson, T. A. & other authors (2006). Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44, 999-1017.
2. Beall, B. W., Gertz, R. E., Jr, Hulkower, R. L., Whitney, C. G., Moore, M. R. & Brueggemann, A. B. (2011). Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 203, 1360-1368.
3. Carvalho, M. da G., Pimenta, F. C., Jackson, D., Roundtree, A., Ahmad, Y., Millar, E. V., O'Brien, K. L., Whitney, C. G., Cohen, A. L. & Beall, B. W. (2010). Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 48, 1611-1618.
4. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing, approved standard, 16th informational supplement, M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
5. CLSI (2011). Performance Standards for Antimicrobial Susceptibility Testing, approved standard, 16th informational supplement, M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Dias, C. A., Teixeira, L. M., Carvalho, M. G. & Beall, B. (2007). Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children. J Med Microbiol 56, 1185-1188.
7. Enright, M. C. & Spratt, B. G. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144, 3049-3060.
8. Moore, M. R., Gertz, R. E., Jr, Woodbury, R. L. G., Barkocy-Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M. & other authors (2008). Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197, 1016-1027.
9. Morais, L., Carvalho, M. da G., Roca, A., Flannery, B., Mandomando, I., Soriano-Gabarró, M., Sigauque, B., Alonso, P. & Beall, B. (2007). Sequential multiplex PCR for identifying pneumococcal capsular serotypes from South-Saharan African clinical isolates. J Med Microbiol 56, 1181-1184.
10. O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S. & Cherian, T. for the Hib and Pneumococcal Global Burden of Disease Study Team (2009). Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374, 893-902.
11. Pai, R., Gertz, R. E., Jr & Beall, B. (2006). Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44, 124-131.
12. Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W. & other authors (2010). Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201, 32-41.
13. Tarragó, D., Aguilar, L., García, R., Gimenez, M. J., Granizo, J. J. & Fenoll, A. (2011). Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother 55, 2297-2302.
14. Toltzis, P., Dul, M. M., O'Riordan, M. A., Jacobs, M. R. & Blumer, J. (2006). Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. Pediatr Infect Dis J 25, 19-24.
15. Waites, K. B., Jones, K. E., Kim, K. H., Moser, S. A., Johnson, C. N., Hollingshead, S. K., Kang, E. S., Hong, K. S. & Benjamin, W. H., Jr (2003). Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea. J Clin Microbiol 41, 5787-5791.
16. Yao, K. H., Wang, L. B., Zhao, G. M., Zheng, Y. J., Deng, L., Huang, J. F., Wang, J. X., Zhao, R. Z., Deng, Q. L. & Hu, Y.-H. (2011). Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine 29, 2296-2301.
17. Zhang, R., Eggleston, K., Rotimi, V. & Zeckhauser, R. J. (2006). Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2, 6.